Prediction of distant metastases in patients with squamous cell carcinoma of head and neck using DWI and DCE-MRI.
diffusion weighted imaging
distant metastases
dynamic contrast enhanced-MRI
intracellular water life time
squamous cell carcinoma of head and neck
volume transfer constant
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
08
11
2019
revised:
30
05
2020
accepted:
26
06
2020
pubmed:
2
8
2020
medline:
22
6
2021
entrez:
2
8
2020
Statut:
ppublish
Résumé
The primary purpose was to evaluate the prognostic potential of diffusion imaging (DWI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in predicting distant metastases in squamous cell carcinoma of head and neck (HNSCC) patients. The secondary aim was to examine differences in DWI and DCE-MRI-derived parameters on the basis of human papilloma virus (HPV) status, differentiation grade, and nodal stage of HNSCC. Fifty-six patients underwent pretreatment DWI and DCE-MRI. Patients were divided into groups who subsequently did (n = 12) or did not develop distant metastases (n = 44). Median values of apparent diffusion coefficient (ADC), volume transfer constant (K Lower but not significantly different K Pretreatment DCE-MRI may be useful in predicting distant metastases in HNSCC.
Sections du résumé
BACKGROUND
The primary purpose was to evaluate the prognostic potential of diffusion imaging (DWI) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in predicting distant metastases in squamous cell carcinoma of head and neck (HNSCC) patients. The secondary aim was to examine differences in DWI and DCE-MRI-derived parameters on the basis of human papilloma virus (HPV) status, differentiation grade, and nodal stage of HNSCC.
METHODS
Fifty-six patients underwent pretreatment DWI and DCE-MRI. Patients were divided into groups who subsequently did (n = 12) or did not develop distant metastases (n = 44). Median values of apparent diffusion coefficient (ADC), volume transfer constant (K
RESULTS
Lower but not significantly different K
CONCLUSION
Pretreatment DCE-MRI may be useful in predicting distant metastases in HNSCC.
Substances chimiques
Contrast Media
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
3295-3306Subventions
Organisme : NIH HHS
ID : R01-CA102756 2004
Pays : United States
Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Cao Y, Wang T, Yu C, Guo X, Li C, Li L. Elective neck dissection versus wait-and-watch policy for oral cavity squamous cell carcinoma in early stage: a systematic review and meta-analysis based on survival data. J Oral Maxillofac Surg. 2019;77(10):2154-2167.
Specenier P, Vermorken JB. Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma. Expert Rev Anticancer Ther. 2018;18:901-915.
Ng JH, Iyer NG, Tan MH, Edgren G. Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck. 2017;39:297-304.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.
Pignon JP, Le Maître A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomized trials and 17,346 patients. Radiother Oncol. 2009;92:4-14.
McBride SM, Ali NN, Margalit DN, Chan AW. Active tobacco smoking and distant metastasis in patients with oropharyngeal cancer. Int J Radiat Oncol Biol Phys. 2012;84:183-188.
Takes RP, Rinaldo A, Silver CE, et al. Distant metastases from head and neck squamous cell carcinoma. Part I. basic aspects. Oral Oncol. 2012;48:775-779.
Madana J, Morand GB, Alrasheed A, et al. Clinical parameters predicting development of pulmonary malignancies in patients treated for head and neck squamous cell carcinoma. Head Neck. 2016;38(Suppl 1):E1277-E1280.
Lallemant B, Evrard A, Chambon G, et al. Gene expression profiling in head and neck squamous cell carcinoma: clinical perspectives. Head Neck. 2010;32:1712-1719.
Coca-Pelaz A, Rodrigo JP, Suárez C. Clinicopathologic analysis and predictive factors for distant metastases in patients with head and neck squamous cell carcinomas. Head Neck. 2012;34:771-775.
Cacicedo J, Fernandez I, Del Hoyo O, et al. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma. Clin Transl Oncol. 2017;19:1337-1349.
Suzuki H, Hasegawa Y, Terada A, et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol. 2009;45:569-573.
Liao CT, Wang HM, Chang JT, et al. Influence of pathological nodal status and maximal standardized uptake value of the primary tumor and regional lymph nodes on treatment plans in patients with advanced oral cavity squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2010;77:421-429.
Yao M, Lu M, Savvides PS, et al. Distant metastases in head-and-neck squamous cell carcinoma treated with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys. 2012;83:684-689.
Haerle SK, Schmid DT, Ahmad N, Hany TF, Stoeckli SJ. The value of (18)F-FDG PET/CT for the detection of distant metastases in high-risk patients with head and neck squamous cell carcinoma. Oral Oncol. 2011;47:653-659.
Meeuwis J, Hoekstra OS, Witte BI, Boellaard R, Leemans CR, de Bree R. 18FDG SUV in the primary tumor and lymph node metastases is not predictive for development of distant metastases in high risk head and neck cancer patients. Oral Oncol. 2015;51:536-540.
Hanamoto A, Takenaka Y, Shimosegawa E, et al. Limitation of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography (FDG-PET) to detect early synchronous primary cancers in patients with untreated head and neck squamous cell cancer. Ann Nucl Med. 2013;27:880-885.
Kim S, Loevner L, Quon H, et al. Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res. 2009;15:986-994.
Kim S, Loevner LA, Quon H, et al. Prediction of response to chemoradiation therapy insquamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. Am J Roentgenol. 2010;31:262-268.
Chawla S, Kim S, Loevner LA, et al. Prediction of disease-free survival in patients with squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging. Am J Neuroradiol. 2011;32:778-784.
Chawla S, Kim S, Dougherty L, et al. Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck. Am J Roentgenol. 2013;200:35-43.
Chawla S, Loevner LA, Kim SG, et al. Dynamic contrast-enhanced MRI-derived intracellular water lifetime (τi): a prognostic marker for patients with head and neck squamous cell carcinomas. Am J Neuroradiol. 2018;39:138-144.
Lambrecht M, Van Calster B, Vandecaveye V, et al. Integrating pretreatment diffusion weighted MRI into a multivariable prognostic model for head and neck squamous cell carcinoma. Radiother Oncol. 2014;110:429-434.
Lombardi M, Cascone T, Guenzi E, et al. Predictive value of pre-treatment apparent diffusion coefficient (ADC) in radio-chemotherapy treated head and neck squamous cell carcinoma. Radiol Med. 2017;122:345-352.
Berrak S, Chawla S, Kim S, et al. Diffusion weighted imaging in predicting progression free survival in patients with squamous cell carcinomas of the head and neck treated with induction chemotherapy. Acad Radiol. 2011;18:1225-1232.
Bernstein JM, Kershaw LE, Withey SB, et al. Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancer. Oral Oncol. 2015;51:508-513.
Shukla-Dave A, Lee NY, Jansen JF, et al. Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head and neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys. 2012;82:1837-1844.
Jansen JF, Carlson DL, Lu Y, et al. Correlation of a priori DCE-MRI and (1)H-MRS data with molecular markers in neck nodal metastases: initial analysis. Oral Oncol. 2012;48:717-722.
Surov A, Meyer HJ, Gawlitza M, et al. Correlations between DCE MRI and histopathological parameters in head and neck squamous cell carcinoma. Transl Oncol. 2017;10(1):17-21.
Meyer HJ, Leifels L, Hamerla G, Höhn AK, Surov A. Associations between histogram analysis parameters derived from DCE-MRI and histopathological features including expression of EGFR, p16, VEGF, Hif1-alpha, and p53 in HNSCC. Contrast Media Mol Imaging. 2019;2019:5081909. https://doi.org/10.1155/2019/5081909.
Surov A, Meyer HJ, Höhn AK, Sabri O, Purz S. Combined Metabolo-volumetric parameters of 18F-FDG-PET and MRI can predict tumor cellularity, Ki67 level and expression of HIF 1alpha in head and neck squamous cell carcinoma: a pilot study. Transl Oncol. 2019;12:8-14.
Klaes R, Friedrich T, Spitkovsky D, et al. Overexpression of p16(INK4A) as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer. 2001;92:276-284.
Song HK, Dougherty L. Dynamic MRI with projection reconstruction and KWIC processing for simultaneous high spatial and temporal resolution. Magn Reson Med. 2004;52:815-824.
Hung YH, Liu SA, Wang CC, Wang CP, Jiang RS, Wu SH. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck. PLoS One. 2018;13:e0205365.
Al-Mamgani A, de Ridder M, Navran A, Klop WM, de Boer JP, Tesselaar ME. The impact of cumulative dose of cisplatin on outcome of patients with head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol. 2017;274:3757-3765.
Bergeron M, Gauthier P, Audet N. Decreasing loco-regional recurrence for oral cavity cancer with total Mohs margins technique. J Otolaryngol Head Neck Surg. 2016;45:63-72.
Khwaja SS, Baker C, Haynes W, et al. High E6 gene expression predicts for distant metastasis and poor survival in patients with HPV-positive oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2016;95:1132-1141.
Pfister DG, Su YB, Kraus DH, et al. Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm. J Clin Oncol. 2006;24:1072-1078.
Haddad R, O'Neill A, Rabinowits G, et al. Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomized phase 3 trial. Lancet Oncol. 2013;14:257-264.
Gao P, Gong L, Wang X. Induction chemotherapy in patients with resectable laryngeal cancer: a meta-analysis. Mol Clin Oncol. 2018;9:155-162.
Wiegand S, Wichmann G, Dietz A. Perspectives of induction with chemo and/or immune check point inhibition in head and neck organ preservation treatment. Front Oncol. 2019;9:191-198.
Bredell MG, Ernst J, El-Kochairi I, Dahlem Y, Ikenberg K, Schumann DM. Current relevance of hypoxia in head and neck cancer. Oncotarget. 2016;7:50781-50804.
Jansen JF, Schöder H, Lee NY, et al. Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and 18F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases. Int J Radiat Oncol Biol Phys. 2010;77:1403-1410.
Thorwarth D, Eschmann SM, Scheiderbauer J, Paulsen F, Alber M. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer. 2005;5:152.
Thorwarth D, Eschmann SM, Paulsen F, Alber M. A model of reoxygenation dynamics of head-and-neck tumors based on serial 18F-fluoromisonidazole positron emission tomography investigations. Int J Radiat Oncol Biol Phys. 2007;68:515-521.
Chang EY, Li X, Jerosch-Herold M, et al. The evaluation of esophageal adenocarcinoma using dynamic contrast-enhanced magnetic resonance imaging. J Gastrointest Surg. 2008;12:166-175.
Li X, Priest RA, Woodward WJ, et al. Cell membrane water exchange effects in prostate DCE-MRI. J Magn Reson. 2012;218:77-85.
Lowry M, Zelhof B, Liney GP, Gibbs P, Pickles MD, Turnbull LW. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue. Invest Radiol. 2009;44:577-584.
Lee SH, Hayano K, Zhu AX, Sahani DV, Yoshida H. Water-exchange-modified kinetic parameters from dynamic contrast-enhanced mri as prognostic biomarkers of survival in advanced hepatocellular carcinoma treated with antiangiogenic monotherapy. PLoS One. 2015;10:e0136725.
Tudorica A, Oh KY, Chui SY, et al. Early prediction and evaluation of breast cancer response to neoadjuvant chemotherapy using quantitative DCE-MRI. Transl Oncol. 2016;9:8-17.
Jajamovich GH, Huang W, Besa C, et al. DCE-MRI of hepatocellular carcinoma: perfusion quantification with Tofts model versus shutter-speed model-initial experience. Magma. 2016;29:49-58.
Koch CJ, Jenkins WT, Jenkins KW, et al. Mechanisms of blood flow and hypoxia production in rat 9L-epigastric tumors. Tumor Microenviron Ther. 2013;1:1-13.
Cooper RA, Carrington BM, Loncaster JA, et al. Tumour oxygenation levels correlate with dynamic contrast-enhanced magnetic resonance imaging parameters in carcinoma of the cervix. Radiother Oncol. 2000;57:53-59.
Chawla S, Kim S, Wang S, Poptani H. Diffusion-weighted imaging in head and neck cancers. Future Oncol. 2009;5:959-975.
Fujima N, Sakashita T, Homma A, Yoshida D, Kudo K, Shirato H. Utility of a hybrid IVIM-DKI model to predict the development of distant metastasis in head and neck squamous cell carcinoma patients. Magn Reson Med Sci. 2018;17:21-27.
Elrefaey S, Massaro MA, Chiocca S, Chiesa F, Ansarin M. HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital. 2014;34:299-309.
Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363:24-35.
Dalianis T. Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy. Int J Oncol. 2014;44:1799-1805.
Wittekindt C, Wagner S, Sharma SJ, et al. HPV-A different view on head and neck cancer. Laryngorhinootologie. 2018;97(1):S48-S113.
Rodrigues RM, Bernardo VG, Da Silva SD, et al. How pathological criteria can impact prognosis of tongue and floor of the mouth squamous cell carcinoma. J Appl Oral Sci. 2019;28:e20190198.
Lindenblatt RC, Martinez GL, Silva LE, Faria PS, Camisasca DR, Lourenço SQ. Oral squamous cell carcinoma grading systems analysis of the best survival predictor. J Oral Pathol Med. 2012;41:34-39.
Sawazaki-Calone I, Rangel A, Bueno AG, et al. The prognostic value of histopathological grading systems in oral squamous cell carcinomas. Oral Dis. 2015;21:755-761.
Boxberg M, Jesinghaus M, Dorfner C, et al. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system. Histopathology. 2017;70:1125-1137.
Choi YS, Park M, Kwon HJ, Koh YW, Lee SK, Kim J. Human papillomavirus and epidermal growth factor receptor in oral cavity and oropharyngeal squamous cell carcinoma: correlation with dynamic contrast-enhanced mri parameters. Am J Roentgenol. 2016;206:408-413.
Jo S, Juhasz A, Zhang K, et al. Human papillomavirus infection as a prognostic factor in oropharyngeal squamous cell carcinomas treated in a prospective phase II clinical trial. Anticancer Res. 2009;29(5):1467-1474.
Xu QS, Wang C, Li B, et al. Prognostic value of pathologic grade for patients with oral squamous cell carcinoma. Oral Dis. 2018;24:335-346.
Mineta H, Miura K, Ogino T, et al. Prognostic value of vascular endothelial growth factor (VEGF) in head and neck squamous cell carcinomas. Br J Cancer. 2000;83:775-781.